IQVIA Holdings Inc. (IQV)

NYSE: IQV · IEX Real-Time Price · USD
240.95 -3.45 (-1.41%)
Jan 21, 2022 4:03 PM EST - Market closed
Market Cap46.03B
Revenue (ttm)13.54B
Net Income (ttm)767.00M
Shares Out191.04M
EPS (ttm)3.93
PE Ratio61.33
Forward PE24.21
Dividendn/a
Ex-Dividend Daten/a
Volume1,108,070
Open245.00
Previous Close244.40
Day's Range239.85 - 248.25
52-Week Range170.00 - 285.61
Beta1.41
AnalystsStrong Buy
Price Target304.28 (+26.3%)
Earnings DateFeb 8, 2022

About IQV

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and dissemin...

IndustryLife Sciences Tools & Services
IPO DateMay 9, 2013
CEOAri Bousbib
Employees77,000
Stock ExchangeNYSE
Ticker SymbolIQV
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 19 analysts, the average rating for IQVIA Holdings stock is "Strong Buy." The 12-month stock price forecast is 304.28, which is an increase of 26.28% from the latest price.

Price Target
$304.28
(26.28% upside)
Analyst Consensus: Strong Buy

News

IQVIA Holdings (IQV) Stock Up 34.4% In a Year: Here's Why

Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.

1 week ago - Zacks Investment Research

Oppenheimer healthcare strategist on why he likes the CRO space in 2022

Jared Holz, Oppenheimer healthcare strategist, joins 'Power Lunch' to discuss the healthcare sector and why biotech companies could struggle the most in the space. For access to live and exclusive video...

Other symbols:SYKXLV
3 weeks ago - CNBC Television

Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now

IQVIA's (IQV) growing client base is a result of the company's ability to standardize, organize and integrate its enormous treasure trove of data.

1 month ago - Zacks Investment Research

Tired of Metaverse Mania? 3 Growth Stocks That Are Great Buys Right Now

Been missing out on other hot growth trends? Get real.

Other symbols:MELI
1 month ago - The Motley Fool

Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19 Vaccines, According to Study ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Global spending on medicines — based on invoice price levels — is expected to grow at 3-6% CAGR through 2026 to reach about $1.8 trillion by 2026, includin...

1 month ago - Business Wire

IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Services Unit

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is l...

1 month ago - Business Wire

3 Technology Services Stocks to Watch Despite Industry Challenges

The Zacks Technology Services industry is likely to benefit from COVID-19-driven dependency on technology, increased digitization and adoption of the multi-cloud model. IQV, STX and BCOR are well positi...

Other symbols:BCORSTX
1 month ago - Zacks Investment Research

IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, was ...

1 month ago - Business Wire

IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engagement Platform

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announ...

2 months ago - Business Wire

IQVIA (IQV) Riding on Global IT Infrastructure, Debt Woe Stays

IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.

2 months ago - Zacks Investment Research

IQVIA (IQV) Beats on Q3 Earnings & Revenues, Raises 2021 View

IQVIA's (IQV) third-quarter 2021 earnings and revenues increase year over year.

3 months ago - Zacks Investment Research

IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates

IQVIA (IQV) delivered earnings and revenue surprises of 1.88% and 0.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

IQVIA Holdings' Beat On Q3 Earnings, Raises FY21 Outlook

IQVIA Holdings Inc (NYSE: IQV) has posted Q3 adjusted EPS of $2.17, up 33% Y/Y, marginally surpassing the consensus of $2.12 Revenue of $3.4 billion increased 21.7% on a reported basis and 21.1 percent ...

3 months ago - Benzinga

IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the lif...

3 months ago - Business Wire

Why IQVIA Holdings (IQV) Might Surprise This Earnings Season

IQVIA Holdings (IQV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

3 months ago - Zacks Investment Research

Is a Beat in Store for IQVIA Holdings (IQV) in Q3 Earnings?

IQVIA's (IQV) third-quarter 2021 earnings and revenues are expected to have improved year over year.

3 months ago - Zacks Investment Research

IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q3 Release

IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

IQVIA to Announce Third-Quarter 2021 Results on October 21, 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2021 financial results before the market opens on Thursday, October 21, 2021. The ...

3 months ago - Business Wire

IQVIA to Host Financial Analyst and Investor Conference on November 16, 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, November 16, 2021. Management will prov...

3 months ago - Business Wire

IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announce...

3 months ago - Business Wire

Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesforce Productivity

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced...

3 months ago - Business Wire

Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now

Solid shareholder-friendly measures and strong healthcare-specific global IT infrastructure boost IQVIA Holdings (IQV) shares.

3 months ago - Zacks Investment Research

IQVIA Holdings' (IQV) Stock Up 44% Year to Date: Here's Why

Encouraging yearly guidance and consecutive better-than-expected top- and bottom-line performances have been aiding IQVIA Holdings' (IQV) stock.

4 months ago - Zacks Investment Research

IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, toda...

Other symbols:NRXP
4 months ago - Business Wire

IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance...

4 months ago - Business Wire